Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Jason Miska, Aida Rashidi, Catalina Lee-Chang, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Polyamines in cancer: integrating organismal metabolism and antitumour immunity
Cassandra E. Holbert, Michael Cullen, Robert A. Casero, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 8, pp. 467-480
Open Access | Times Cited: 197
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang, Aida Rashidi, Junfei Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer
Federica Cappellesso, Marie‐Pauline Orban, Niranjan Shirgaonkar, et al.
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1464-1483
Open Access | Times Cited: 75
Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer
Min-Sik Lee, Courtney Dennis, Insia Naqvi, et al.
Nature (2023) Vol. 616, Iss. 7956, pp. 339-347
Open Access | Times Cited: 75
Control of tumor-associated macrophage responses by nutrient acquisition and metabolism
Xian Zhang, Liangliang Ji, Ming O. Li
Immunity (2023) Vol. 56, Iss. 1, pp. 14-31
Open Access | Times Cited: 66
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
Μαρκέλλα Ζαννίκου, Joseph Duffy, Rebecca Levine, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006239-e006239
Open Access | Times Cited: 43
Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Corey Dussold, Kaylee Zilinger, Jillyn Turunen, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 17
DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling
Rong Shen, Disheng Liu, Xiaoning Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 42
Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer and Autoimmunity
Tzu-Yi Chia, Andrew Zolp, Jason Miska
Cells (2022) Vol. 11, Iss. 5, pp. 896-896
Open Access | Times Cited: 41
Next-generation antigen-presenting cell immune therapeutics for gliomas
Catalina Lee-Chang, Maciej S. Lesniak
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 30
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Aida Rashidi, Leah K. Billingham, Andrew Zolp, et al.
Cell Metabolism (2023) Vol. 36, Iss. 1, pp. 62-77.e8
Closed Access | Times Cited: 26
Polyamines: the pivotal amines in influencing the tumor microenvironment
Cassandra E. Holbert, Robert A. Casero, Tracy Murray Stewart
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
Claire Vinel, James Boot, Weiwei Jin, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Linking macrophage metabolism to function in the tumor microenvironment
Robbie Jin, Luke Neufeld, Tracy L. McGaha
Nature Cancer (2025)
Closed Access | Times Cited: 1
NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding
Daniel C. Levine, Hsin-Yu Kuo, Hee‐Kyung Hong, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1621-1632
Open Access | Times Cited: 48
Mono-(2-ethyl-5-hydroxyhexyl) phthalate promotes uterine leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation
Takashi Iizuka, Ping Yin, Azna Zuberi, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 47
Open Access | Times Cited: 38
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Amy B. Heimberger, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 839-854
Open Access | Times Cited: 37
Targeting lactate metabolism for cancer immunotherapy - a matter of precision
Christoph Heuser, Kathrin Renner, Marina Kreutz, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 32-45
Open Access | Times Cited: 37
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 163-186
Open Access | Times Cited: 35
Targeting amino acid metabolism in cancer
Lucie Safrhansova, Kateřina Hložková, Júlia Starková
International review of cell and molecular biology (2022), pp. 37-79
Closed Access | Times Cited: 29
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
Michael D. Hogarty, David S. Ziegler, Andrea Franson, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 5, pp. 788-797
Open Access | Times Cited: 8
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies
Xijiao Ren, Rui Xue, Yan Luo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Potential for New Therapeutic Approaches by Targeting Lactate and pH Mediated Epigenetic Dysregulation in Major Mental Diseases
Shabnam Nohesara, Hamid M. Abdolmaleky, Sam Thiagalingam
Biomedicines (2024) Vol. 12, Iss. 2, pp. 457-457
Open Access | Times Cited: 7
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Kwangsoo Kim, Karl J. Habashy, Andrew Gould, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 2044-2060
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top